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Chlamydia trachomatis neither 
exerts deleterious effects on 
spermatozoa nor impairs male 
fertility
Jenniffer Puerta Suarez1,2, Leonardo R. Sanchez1, Florencia C. Salazar1, Hector A. Saka1, Rosa 
Molina3, Andrea Tissera3, Virginia E. Rivero1, Walter D. Cardona Maya2 & Ruben D. Motrich1
Chlamydia trachomatis is the most prevalent sexually transmitted bacterial infection. However, 
whether Chlamydia trachomatis has a negative impact on sperm quality and male fertility is still 
controversial. Herein, we report the effects on sperm quality of the in vitro exposure of spermatozoa 
to Chlamydia trachomatis, and also the effects of male genital infection on male fertility using an 
animal model. Human and mouse sperm were obtained from healthy donors and cauda epididimys 
from C57BL/6 mice, respectively. Highly motile human or mouse spermatozoa were in vitro exposed 
to C. trachomatis (serovar E or LGV) or C. muridarum, respectively. Then, sperm quality parameters 
were analyzed. Moreover, male fertility of Chlamydia muridarum infected male C57BL/6 mice was 
assessed. Human or murine sperm in vitro exposed to increasing bacterial concentrations or soluble 
factors from C. trachomatis or C. muridarum, respectively, did not show differences in sperm motility 
and viability, apoptosis, mitochondrial membrane potential, DNA fragmentation, ROS production and 
lipid peroxidation levels, when compared with control sperm (p > 0.05). Moreover, no differences in 
fertility parameters (potency, fecundity, fertility index, pre- and post-implantation loss) were observed 
between control and infected males. In conclusion, our results indicate that Chlamydia spp. neither 
directly exerts deleterious effects on spermatozoa nor impairs male fertility.
Chlamydia trachomatis (CT) is the most prevalent sexually transmitted bacterial pathogen in humans and the 
most common infection among sexually active young adults1. Yearly, approximately 100 million new cases of 
genital CT infections are diagnosed worldwide, although this is probably an underestimation2. Moreover, up 
to 90% infections in women and 50% in men are subclinical or asymptomatic1, favoring bacterial spread. The 
prevalence of chlamydial genital infections is similar in males and females; however, most current research in the 
field and screening strategies have been mainly focused on females3, neglecting the importance of CT infections 
of the male genital tract (MGT).
In the natural infection, male to female/male transmission is due to chlamydial elementary bodies (EBs) that 
are free in the seminal plasma or in infected epithelial cells from the MGT during sexual intercourse. Clinical 
manifestations in women include acute urethritis, bartholinitis, mucopurulent cervicitis, endometritis, salpin-
gitis, pelvic inflammatory disease, perihepatitis, periappendicitis and reactive arthritis1, 4. Untreated infections 
in women lead to severe reproductive complications including pelvic inflammatory disease, chronic pelvic pain, 
ectopic pregnancy, miscarriage and tubal infertility4. In men, CT causes urethritis, prostatitis, epididymitis and 
epididymis-orchitis5, 6. Moreover, chronic chlamydial male genital infections have been suggested as possible 
causes of infertility in recent years7, 8. However, whether CT infections of the MGT impair sperm quality and male 
fertility is a controversial issue6, 7. A clear association of CT infections of the MGT and male infertility has not yet 
been proven6–10. Some in vitro studies have proposed that CT interacts with sperm cells, affecting their function 
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and inducing apoptosis11–15. However, these findings had not been reproduced in in vivo studies16. Besides, some 
evidence published over two decades ago showed a possible direct interaction and internalization of CT into 
sperm cells17, 18, with significant implications for assisted reproduction technology. To date, and to the best of 
our knowledge, similar results have not been reported. In summary, the limited available data is conflicting and 
compelling evidence establishing a clear relationship between CT infection and sperm/semen quality is currently 
lacking.
Herein, we report the effects on sperm quality of the in vitro exposure of human and murine spermatozoa 
to CT and Chlamydia muridarum, respectively. Moreover, and using a mouse model of genital tract chlamydial 
infection, we assessed the effects of C. muridarum infection of the MGT on male fertility. Finally, we also evalu-
ated if Chlamydia spp. attach to spermatozoa using in vitro and in vivo approaches.
Results
Chlamydia spp. does not impair sperm motility and viability. Figure 1a–e shows the effects on sperm 
motility and viability of the co-incubation of human sperm with three different concentrations of CT serovar E 
or LGV during 6 h. As shown, similar levels of sperm motility were observed in human sperm incubated with 
either CT serovar E or LGV as those observed in control sperm (sperm incubated with medium alone) (Fig. 1a,b). 
On the contrary, as previously reported19, the exposure of human sperm to 1 × 106 CFU/ml of viable Escherichia 
coli significantly decreased sperm motility (Fig. 1a,b). In addition, similar results were observed when analyzing 
sperm viability (Fig. 1c,d). Accordingly, sperm plasma membrane integrity evaluation, as an additional meas-
ure of sperm viability, showed no significant differences between control spermatozoa (incubated with medium 
alone) and spermatozoa co-incubated with CT, either serovar E or LGV (Fig. 1e). Furthermore, similar results 
were observed when assaying highly motile fractions of human sperm samples in vitro exposed to CT, either ser-
ovar E or LGV, during 24 h (Supplementary Fig. 1). Since soluble factors of other bacteria such as E. coli have been 
shown to alter sperm19, the effects of soluble factors of CT on sperm motility and viability were also analyzed. 
Fractions of highly motile human spermatozoa were co-incubated with supernatants obtained from HeLa cell 
cultures after 48 h of infection with CT serovar E or LGV at three different concentrations. Mean values of motility 
or viability from spermatozoa exposed to soluble factors from CT, either serovar E or LGV, showed no significant 
differences when compared with values from spermatozoa co-incubated with supernatants from uninfected cul-
tures (Medium) (Supplementary Fig. 2).
In agreement with these results, C. muridarum did not exert deleterious effects on murine sperm viability 
(Fig. 1f).
Chlamydia spp. does not induce sperm apoptosis. In vitro exposure of spermatozoa to CT did not 
induce sperm apoptosis since similar levels of early (A+/PI−) or late (A+/IP+) apoptosis were observed in 
human spermatozoa incubated with either CT serovar E or LGV, at any bacterial concentration assessed, when 
compared with control spermatozoa (Table 1). Moreover, levels of early or late apoptosis in spermatozoa incu-
bated with cLPS were similar to those observed in control spermatozoa (Table 1). However, significantly elevated 
levels of early apoptosis were detected in human spermatozoa incubated with E. coli or with LPS purified from E. 
coli (E. coli LPS) (Table 1), as previously reported19. Furthermore, similar results were observed when analyzing 
murine spermatozoa incubated with C. muridarum, cLPS, E. coli LPS, or E. coli (Table 1).
As shown in Table 2, no significant differences were observed in sperm mitochondrial functionality (ΔΨm) 
or DNA fragmentation levels in human spermatozoa co-incubated with CT, either serovar E or LGV, when com-
pared with control spermatozoa (vehicle). Similar results were observed when analyzing the effects of soluble 
factors from CT serovar E or LGV (Supplementary Table 1). Altogether, these data indicate that Chlamydia spp. 
do not exert toxic effects on spermatozoa under the experimental conditions assayed.
CT neither induces sperm ROS production nor membrane lipid peroxidation. Since it has been 
reported that bacteria such as E. coli induce sperm ROS production and membrane lipid peroxidation20, ROS 
production and lipid peroxidation were analyzed in human spermatozoa co-incubated with different concen-
trations of CT, serovar E or LGV, or their soluble factors. No significant differences were observed in either ROS 
production (Fig. 2a,b) or membrane lipid peroxidation (Fig. 2c) levels in spermatozoa co-incubated with CT 
serovar E or LGV when compared with their respective control counterparts (vehicle), or when assaying soluble 
factors of CT serovar E or LGV (Supplementary Fig. 3). Hence, CT does not induce either sperm oxidative stress 
or membrane lipid peroxidation.
C. muridarum infection of the male genital tract does not impair male fertility. Considering results 
shown above, we then aimed to test the effects of chlamydial infection of the MGT on male fertility in vivo using an 
animal model in mice. In this regard, the development and study of murine models of C. muridarum infection of the 
MGT have been pioneered by our group6, 21–23. These models have shown that inoculated rats and mice develop an 
ascending chlamydial infection that is detectable in semen and male genital tract tissues, showing special tropism for 
the prostate and persisting even until 80 dpi21–23. As previously described23, C57BL/6 male mice were inoculated in 
the meatus urethra with C. muridarum or vehicle, and mating experiments were performed to analyze different fer-
tility parameters. Once mating experiments were performed, sham infected and infected male mice were euthanized 
to confirm the presence of infection by screening C. muridarum DNA in prostate tissue samples. C. muridarum was 
detected in 100% of prostate tissue samples from infected animals after 20 days of inoculation (Table 3). Negative 
results were obtained in prostate tissue samples from sham infected mice.
Mating experiments with sexually mature female C57BL/6 mice revealed no significant differences in the 
ability of sham infected and infected male mice to mate (potency) (Table 3). Moreover, no significant differences 
were found in fecundity potential between the sham infected and infected groups. When the fertility index was 
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Figure 1. Effects of Chlamydia spp. on sperm motility and viability. Human sperm motility (%) after 6 h of in 
vitro incubation without bacteria (Control), or with increasing concentrations of EBs of CT serovar E (a) or 
serovar LGV (b) per million spermatozoa. Human sperm viability (%) after 6 h of in vitro incubation without 
bacteria (Control), or with increasing concentrations of EBs of CT serovar E (c) or serovar LGV (d) per million 
spermatozoa. (e) Sperm membrane integrity (%) in human spermatozoa after in vitro incubation without 
bacteria (Control), or with increasing concentrations of EBs of CT serovar E or serovar LGV per million 
spermatozoa. (f) Murine sperm viability (%) after 30 min of in vitro incubation without bacteria (Control) 
or with increasing concentrations of EBs of C. muridarum per million spermatozoa. As positive controls, 
sperm fractions were incubated with uropathogenic E. coli (1 × 106 CFU/mL). Data are shown as mean ± SD. 
Fractions of human (n = 54) and mouse (n = 24) sperm samples were tested separately and maintained at 37 °C 
throughout all procedures. Statistical analysis was performed using one-way ANOVA with Bonferroni post hoc 
test analysis and no significant differences were found in any condition (p < 0.05).
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analyzed, no significant difference was found between infected and control males (Table 3). In addition, females 
mated with infected males had similar pre-implantation and post-implantation embryo loss compared to the 
sham infected group (Table 3). Overall, these results indicate that C. muridarum infection of the MGT does not 
compromise male fertility.
Chlamydia spp. do not attach to spermatozoa. Some controversial evidence published more than two 
decades ago suggested that CT tightly interacts with and/or internalizes into spermatozoa17, 18, having signifi-
cant implications for assisted reproduction technology. Taking this into consideration, we finally tested whether 
Chlamydia spp. is able to attach to spermatozoa by conducting different experimental approaches.
First, fractions of human spermatozoa were incubated with different concentrations of green fluorescent EBs 
of CT (GFP-CT). Then, sperm suspensions were subjected to five consecutive washes with BSA-supplemented 
BWW medium to remove free bacteria, and smeared on slides that were analyzed by fluorescent confocal micros-
copy. As observed in Fig. 3, abundant EBs of GFP-CT (observed as green/blue co-localizing dots) were observed 
in fractions of sperm samples incubated with 1 × 107 EBs/mL before washes (positive control, 1 × 107 EBs 
pre-washes). Noteworthy, EBs of CT were observed free and detached from or not interacting with spermatozoa. 
Moreover, washing sperm suspensions with supplemented medium after incubation removed bacteria in every 
rate of bacterial concentration assayed indicating that CT does not attach to human spermatozoa in vitro [Fig. 3: 
compare 1 × 105, 1 × 106 or 1 × 107 EBs post-washes with the negative control (Vehicle), pre-washes].
Second, 1 × 106 human spermatozoa were incubated with 1 × 105, 1 × 106 or 1 × 107 EBs of CT serovar E. Then, 
sperm suspensions were subjected to five consecutive washes with BSA-supplemented BWW medium to remove 
free bacteria, and finally inoculated onto in vitro cultured HeLa cell monolayers. After 48 h, the presence of infec-
tion was investigated by performing immunofluorescent detection of chlamydial inclusions. Figure 4a shows that 
inoculation of cultures with either 1 × 106 EBs of CT (positive control) or sperm incubated with three different 
concentrations of CT without posterior washes to remove free bacteria, resulted in the expected infection of 
HeLa cells. However, no infection was observed when inoculating cultures with spermatozoa pre-incubated with 
1 × 105, 1 × 106 or 1 × 107 EBs/million sperm and then washed to remove free bacteria (Fig. 4a). As expected, no 
infection was detected in cultures inoculated with control sperm (sperm incubated with medium alone, negative 
control). Thus, the fact that washing sperm suspensions (previously co-incubated with CT) prevented the poste-
rior infection of inoculated HeLa cell cultures strongly suggests that CT does not attach to spermatozoa in vitro.
Lastly, an in vivo approach consisting in vaginal insemination of female C57BL/6 mice with mouse sperm 
in vitro pre-incubated with C. muridarum was conducted. C. muridarum infection was determined by assaying 
the expression of the chlamydial omp2 gene by traditional PCR and quantitative PCR (qPCR) in vaginal lavages 
at 7 days post insemination (dpi) (Fig. 4b), and in vaginal and uterine tissue at 15 dpi (Fig. 4b,c). As expected, 
C. muridarum was detected in either vaginal lavages (7 dpi, Fig. 4b) or in vaginal/uterine tissue samples (15 dpi, 
Fig. 4b,c) from females inseminated with spermatozoa pre-incubated with 1 × 106 C. muridarum EBs/million 
Sperm Apoptosisa
Experimental condition Live (A−/PI−)
Live, early 
apoptotic (A+/
PI−)
Dead, late 
apoptotic/
early 
necrotic 
(A+/PI+)
Dead, Late 
necrotic 
(A−/PI+)
Human sperm
Vehicle 76.9 ± 2.5 20.3 ± 3.3 2.1 ± 0.7 0.7 ± 0.4
Chlamydia trachomatis 
Serovar E
1 × 105 EBs 71.7 ± 3.3 21.2 ± 0.7 3.8 ± 1.6 3.3 ± 1.6
1 × 106 EBs 72.0 ± 3.0 23.7 ± 4.2 3.2 ± 0.7 1.1 ± 0.5
1 × 107 EBs 68.7 ± 2.8 19.7 ± 7.0 5.2 ± 1.4 6.4 ± 5.3
Chlamydia trachomatis 
Serovar LGV
1 × 105 EBs 69.0 ± 2.7 25.6 ± 1.5 3.8 ± 1.6 1.6 ± 1.1
1 × 106 EBs 74.2 ± 4.0 20.6 ± 4.2 4.3 ± 0.5 0.9 ± 0.4
1 × 107 EBs 79.7 ± 2.3 14.7 ± 2.8 4.2 ± 0.3 1.4 ± 0.4
Chlamydial LPS 72.3 ± 0.4 22.0 ± 2.6 4.4 ± 1.6 1.3 ± 0.7
E. coli LPS 36.8 ± 5.7* 37.8 ± 7.2* 17.6 ± 3.6* 7.8 ± 13.5*
E. coli 37.1 ± 5.9* 28.3 ± 6.9* 24.9 ± 6.4* 9.7 ± 2.9*
Murine sperm
Vehicle 59.0 ± 5.5 12.9 ± 6.2 27.5 ± 3.3 0.6 ± 0.4
Chlamydia muridarum
1 × 105 EBs 54.7 ± 7.6 8.2 ± 4.2 35.9 ± 4.4 1.2 ± 0.6
1 × 106 EBs 53.0 ± 3.8 15.3 ± 6.3 31.1 ± 3.1 0.6 ± 0.1
1 × 107 EBs 55.4 ± 9.2 14.6 ± 5.5 29.2 ± 7.5 0.8 ± 0.7
Chlamydial LPS 58.8 ± 7.9 18.9 ± 3.5 22.0 ± 6.1 0.3 ± 0.1
E. coli LPS 12.9 ± 3.4* 72.8 ± 8.8* 13.9 ± 5.3* 0.4 ± 0.1
E. coli 18.7 ± 4.6* 26.5 ± 16.5 51.4 ± 13.6* 3.4 ± 2.6*
Table 1. Chlamydia spp. and sperm apoptosis. aLevels (%) of apoptosis/necrosis in human and murine sperm 
after 6 h or 30 min, respectively, of in vitro incubation with increasing concentrations of Chlamydia spp. EBs, or 
with cLPS, E. coli LPS, or 1 × 106 CFU of E. coli/million sperm. Data are shown as mean ± SD. Human (n = 54) 
and mouse (n = 24) sperm samples were tested separately and maintained at 37 °C throughout all procedures. 
Statistical analysis was performed using one-way ANOVA with Bonferroni post hoc test analysis. *p < 0.05.
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spermatozoa without further washes (Positive control). Conversely, no infection was detected in either vaginal 
lavages (7 dpi) (Fig. 4b) or in genital tract tissue samples (15 dpi) (Fig. 4b,c) from females inseminated with sperm 
suspensions pre-incubated with 1 × 106 or 1 × 107 EBs of C. muridarum EBs/million sperm that were then washed 
5 times to remove free bacteria. Taken together, these results mirrored those from the in vitro experiments shown 
above, indicating that Chlamydia spp. do not attach to spermatozoa in vitro, which have significant implications 
for assisted reproduction technology.
Discussion
Herein, using different experimental in vitro approaches and an animal model of infection, we provide evidence 
indicating that Chlamydia spp. neither significantly exerts deleterious effects on spermatozoa nor impairs male 
fertility in vivo. Our results show that CT serovars E and LGV do not impair human sperm motility and viabil-
ity in vitro. Moreover, CT or its soluble factors including cLPS do not induce sperm apoptosis, mitochondrial 
Sperm mitochondrial membrane potential, ΔΨm (%)a
CT Serovar E Serovar LGV
Sample Vehicle Control+ 1 × 105 EBs 1 × 106 EBs 1 × 107 EBs Vehicle Control+ 1 × 105 EBs 1 × 106 EBs 1 × 107 EBs
High ΔΨm 54.2 ± 3.8 45.2 ± 2.9* 55.0 ± 3.9 55.7 ± 8.4 51.1 ± 6.9 63.3 ± 6.2 48.3 ± 6.5* 67.5 ± 15.5 59.7 ± 5.4 58.3 ± 6.8
Low ΔΨm 20.1 ± 6.5 7.7 ± 2.2* 21.1 ± 4.4 19.1 ± 8.3 23.0 ± 7.8 16.2 ± 4.5 6.5 ± 2.7* 12.3 ± 7.0 20.0 ± 8.3 20.0 ± 7.3
Sperm DNA fragmentationb
DNA fragmentation 
index 4.0 ± 1.0 15.6 ± 0.7* 4.2 ± 0.6 4.3 ± 2.2 3.5 ± 2.6 3.1 ± 2.6 17.1 ± 1.1* 4.1 ± 1.3 5.3 ± 3.6 2.9 ± 1.3
Table 2. Effects of CT on the mitochondrial physiology and DNA integrity of human sperm. Percentages of 
human sperm exhibiting high and low mitochondrial membrane potential (ΔΨm)a, and evaluation of DNA 
fragmentationb, in human sperm samples after 6 h of in vitro incubation without bacteria (Vehicle), or with 
increasing concentrations of EBs of CT serovar E or serovar LGV. Data are shown as mean ± SD, n = 36. 
Statistical analysis was performed using one-way ANOVA with Bonferroni post hoc test analysis. *p < 0.05.
Figure 2. ROS production and lipid peroxidation in human spermatozoa exposed to CT. Analysis of ROS 
production by human spermatozoa after 6 h of in vitro incubation without bacteria (Vehicle), 100 nM PMA 
(positive control) or with increasing concentrations of EBs of CT serovar E or serovar LGV per million 
spermatozoa. ROS production was assessed by flow cytometry using the probe DCFH-DA that fluoresces when 
oxidized to DCFH. (a) Histograms show sperm with ROS production (M1). (b) ROS production levels (MFI) 
are shown in bars. (c) Human sperm membrane lipid peroxidation (%) after 6 h of in vitro incubation without 
bacteria (Vehicle), 100 mM TBHP (positive control) or with increasing concentrations of EBs of CT serovar E or 
serovar LGV per million spermatozoa. Lipid peroxidation was analyzed using BODIPY C11. Data are shown as 
mean ± SD. Fractions of sperm samples (n = 36) were tested separately. Statistical analysis was performed using 
one-way ANOVA with Bonferroni post hoc test analysis. *p < 0.05.
www.nature.com/scientificreports/
6Scientific RepoRts | 7: 1126  | DOI:10.1038/s41598-017-01262-w
dysfunction and DNA fragmentation. Also, no significant levels of either ROS production or membrane lipid 
peroxidation were detected in human sperm incubated with CT serovar E or LGV. Similar results were obtained 
when assaying murine sperm in vitro exposed to C. muridarum. Finally, and using a mouse model of infec-
tion21–23, no differences in the male fertility parameters assayed (potency, fecundity, fertility index, pre- and 
post-implantation embryo loss) were observed between control and C. muridarum infected males.
Fertility parameters
Parameter (mean ± SD)
Experimental groups
Control Infected
C. muridarum infected males 0/6 (0%) 6/6 (100%)
% Potent 79.3 81.3
% Fecund 100 100
Fertility index 0.92 ± 0.06 0.93 ± 0.11
% embryo loss
Before implantation 8.75 ± 6.52 7.87 ± 13.53
After implantation 14.38 ± 12.06 9.61 ± 12.20
Table 3. Effects of C. muridarum infection of the male genital tract on male fertility. Evaluation of fertility 
parameters of control and C. muridarum infected male mice. Six-to-eight week old male C57BL/6 mice were 
inoculated in the meathus urethra with 20 μL of vehicle (SPG, Control group, n = 6) or with a suspensión 
containing 1 × 108 EBs of C. muridarum (Infected group, n = 6). After 15 days of inoculation, males were 
mated with sexually mature female C57BL/6 mice to evaluate fertility parameters. Every male was mated with 3 
females (a total of 36 females, n = 18 females per experimental group). Data are shown as mean ± SD. Statistical 
analysis was performed using two-way ANOVA with Bonferroni post hoc test analysis (p > 0.05).
Figure 3. CT does not attach to spermatozoa in vitro. Fractions of highly motile human sperm samples 
containing 1 × 106 sperm/ml were in vitro incubated with 3% BSA supplemented BWW medium alone or with 
1 × 105, 1 × 106 and 1 × 107 EBs/mL of GFP-CT (green fluorescent) during 6 h at 37 °C. Sperm suspensions 
were then subjected to five consecutive washes and centrifuged at 300 × g for 5 min to remove free bacteria 
(Post-washes). Sperm suspensions were smeared onto glass slides, stained with DAPI (stain for DNA) and 
counterstained with 0.01% Evans blue and analyzed by confocal microscopy. Negative control corresponds to 
fractions of sperm samples incubated with supplemented BWW medium alone [Negative control (Vehicle), 
Pre-washes]. Positive control corresponds to fractions of sperm samples incubated with 1 × 107 EBs of GFP-CT 
without subsequent washings [Positive control (1 × 107 EBs), Pre-washes]. Green fluorescent EBs of GFP-CT 
are observed as green/blue co-localizing dots (marked with arrows). Results shown are from one representative 
experiment out of three performed (using fractions of n = 10 different sperm samples) with essentially the same 
results. Images were captured using an Olympus FV1200 laser scanning confocal microscope with an objective 
PLAPON 60X (1.42 NA). Fluorophore signals were acquired in sequential mode.
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It has been estimated that 15% of male infertility is related to genital tract infection and inflammation24. 
Sexually transmitted infections account for 340 million new cases occurring each year worldwide25. Among them, 
the most prevalent bacterial infections are those caused by CT9. The impact of CT infection on female fertility 
Figure 4. Spermatozoa do not carry attached EBs of Chlamydia spp. (a) In vitro cultured confluent HeLa cells 
were inoculated with human spermatozoa in vitro pre-incubated with different concentration rates (1 × 105, 
1 × 106 or 1 × 107 EBs/million sperm) of CT serovar E, immediately after incubation without removing bacteria 
(Pre-washes), or after five consecutive washes post-incubation (Post-washes) in order to remove free bacteria. 
Some cultured cells were directly inoculated with 1 × 106 EBs of CT serovar E/mL (positive control) or with 
supplemented BWW medium alone (negative control). After 48 h of culture, infection of cultures was assessed 
by the detection of chlamydial inclusion bodies by direct immunofluorescence using a FITC-labeled anti-cLPS 
monoclonal antibody. Representative microphotographs of 1 out of 4 independent experiments performed with 
essentially the same results. (b and c) C. muridarum detection (omp2 gene) by conventional (b) or real time 
PCR (qPCR) (c) in vaginal lavages (at 7 days post insemination) and female genital tract tissue samples (at 15 
days post insemination) from female C57BL/6 mice that were intravaginally inseminated with murine sperm 
in vitro pre-incubated with C. muridarum in capacitating conditions and then washed 5 times to remove free 
bacteria. Four experimental groups were included: the sham infected group (n = 6) inseminated with 30 µl of 
a solution containing 1 × 106 sperm that were pre-incubated with vehicle alone (BWW buffer); the positive 
control group (n = 6) inseminated with 30 µl of a solution containing 1 × 106 sperm that were pre-incubated 
with 1 × 107 EBs of C. muridarum without subsequent washings; one group (n = 6) inseminated with 30 µl of a 
solution containing 1 × 106 sperm that were pre-incubated with 1 × 106 EBs of C. muridarum and then washed 
5 times; and one group (n = 6) inseminated with 30 µl of a solution containing 1 × 106 sperm that were pre-
incubated with 1 × 107 EBs of C. muridarum and then washed 5 times. The expression of the housekeeping gene 
eef2 was assayed. Representative data from 1 out of 3 independent experiments performed with essentially the 
same results. Data are shown as mean ± SD. Statistical analysis was performed using two-way ANOVA with 
Bonferroni post hoc test analysis. *p < 0.01.
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has already been established4, 9. While it is clear that the inflammation caused during chlamydial infection has 
detrimental effects on the female reproductive tract itself, it largely remains controversial if chlamydial infection 
has a significant effect on sperm quality and subsequently on male fertility6–8. In this regard, CT could directly 
damage the sperm by direct contact or its soluble products, or indirectly through the induction of tissue inflam-
mation and the release of toxic inflammatory mediators such as ROS and cytokines. Thus, additional studies in 
patients and new studies research conducting in vitro and in vivo approaches are needed to improve the current 
understanding of this topic.
On one hand, some epidemiological reports indicate that CT infection of the MGT is associated with a 
decrease in sperm concentration, viability, motility and normal morphology26, 27. Conversely, most other stud-
ies have revealed no significant association between CT infection of the MGT and altered sperm quality28–33. 
Interestingly, it has been shown that men co-infected with CT and Mycoplasma spp. had increased levels of sperm 
with fragmented DNA34. Nonetheless, these effects are more likely due to Mycoplasma spp. infection rather than 
CT infection8, 25. Moreover, alterations in semen quality have been reported in prostatitis patients co-infected with 
CT and human papillomavirus (HPV) but not in patients only infected with CT35. Remarkably, the co-infection 
with other genital pathogens such as HPV, Ureaplasma spp., or Mycoplasma spp. rather than the sole CT infection 
appears to have deleterious effects in semen quality.
On the other hand, evidence from animal models of CT infection of the MGT is scarce. Recently, Sobinoff 
et al. showed that intrapenile inoculation with C. muridarum in mice caused an ascending infection and, once 
in testes, it damaged male germ cells and Sertoli cells 4–8 weeks post infection36. However, the semen quality of 
these infected animals was not assessed. This would have been an interesting aspect to be addressed in order to 
ascertain if the infection had an impact on semen quality. Besides, intrapenile inoculation of bacteria could be 
forcing infection rather than reflecting the course of natural infections. In experimental models of MGT infec-
tion, it is important to induce the infection through the natural route to obtain results comparable to natural 
infections. In fact, and mirroring natural infections, the inoculation of C. muridarum in the meatus urethra of 
male rats and mice causes an ascending infection of the MGT21–23. Semen analysis of infected animals showed 
that, either acute or chronic CT infection of the MGT, have no detrimental consequences in sperm quality, either 
from semen or epididymis22. Moreover, these animals showed to have their male fertility potential unimpaired 
when compared to control non-infected males22.
Some in vitro studies have proposed that CT interacts with sperm cells, affecting their function and inducing 
apoptosis, effects that were reported to be more pronounced for serovar E than for LGV12–15. Hosseinzadeh et al. 
indicated that these effects were induced by live bacteria but not by bacterial soluble products or membrane com-
ponents, since the effects were not observed when co-incubating spermatozoa with heat-killed CT12. However, in 
a posterior work, these authors showed that LPS from both CT serovars, E and LGV, provoked a marked reduc-
tion in sperm motility similar to that observed in response to EBs from CT serovar E13. Moreover, they also pro-
posed that chlamydial LPS, through its binding to CD14 on the sperm surface, could trigger ROS production and 
caspase-mediated apoptosis13, 14, clearly contradicting their previous findings. Furthermore, these authors failed 
to confirm their findings in in vivo studies16 and recently reported no significant differences in sperm quality and 
inflammatory cytokines levels in semen from control and CT-infected male individuals28. Also, they reported that 
current or past CT infections in male partners of infertile couples have no influence on the chance of pregnancy 
or pregnancy outcome37.
Noteworthy, most conflicting data on CT and sperm quality come from the available in vitro studies. Therefore, 
additional and compelling evidence is needed to clearly establish whether CT infection alters sperm quality and 
male fertility. Herein, we provide new evidence indicating that the direct in vitro exposure of spermatozoa to CT 
neither impairs sperm motility and viability nor induces sperm apoptosis. In addition, CT or its soluble factors 
including cLPS do not induce sperm apoptosis, mitochondrial dysfunction or DNA fragmentation. Most of these 
findings are supported by similar results observed when analyzing murine spermatozoa in vitro exposed to C. 
muridarum, the particular species of Chlamydia that naturally infect rodents6. Interestingly, our results are in 
contrast to some previously reported data12–15. Differences in experimental conditions and samples used may 
account, at least in part, for the discrepancies observed. Nevertheless, our results are strengthened by having 
obtained consistent results evaluating different conventional, non-conventional and functional sperm parame-
ters, broadly different doses of different species and biovars of Chlamydia spp., incubation times, and sperm from 
different species. Our results also show that CT neither induces sperm ROS production nor membrane lipid per-
oxidation. Although we found, as previously reported, that other common bacteria such as E. coli induced sperm 
ROS production and membrane lipid peroxidation20 that was not the case for CT in our experimental setting. 
The latter results are supported by evidence showing that CT rapidly targets and shuts down NADPH activity 
thus down-regulating ROS production38. However, the exact mechanism of such down-regulation remains to be 
elucidated.
Our results also indicate that Chlamydia spp. infection of the MGT does not alter male fertility. Using a mouse 
model of male genital infection and performing mating studies with sexually mature female mice, we observed 
no differences in different fertility parameters, i.e. potency, fecundity, fertility index and embryo loss (before and 
after implantation), between control and infected males. These data from in vivo studies are very valuable since 
they contemplate the possibility that Chlamydia spp. may also damage sperm indirectly through the induction 
of inflammation or damage of the reproductive organs. Interestingly, our results demonstrate that chlamydia 
infected male mice showed similar male fertility potential as control males, in agreement with previously reported 
data in male Wistar rats22. Besides, it has been recently reported that CT-infected patients have no increased levels 
of pro-inflammatory cytokines in semen when compared to control subjects28. Moreover, it was reported that 
once Chlamydia spp. infects the genital tract, they induce IL10-secreting B regulatory cells that modulates the 
induction of protective Th1 immune responses preventing tissue inflammation and favoring the establishment of 
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chronic infections39. However, if Chlamydia infection ascends to the epididymis or testis, epididymal or testicular 
function may be affected resulting in an altered sperm quality and compromised male fertility.
The present study also provides evidence suggesting that Chlamydia spp. do not attach to spermatozoa in vitro. 
Using electron microscopy, some early studies showed a possible close interaction between CT and sperm cells 
in biopsy specimens of the testis and epididymis, as well as in semen17, 18, 40. In addition, these studies proposed 
that CT could be internalized into spermatozoa having important implications for assisted reproduction tech-
nology. However, to the best of our knowledge, no similar results have been reported up to date. Moreover, in a 
later study, these authors failed to confirm that spermatozoa play a role in the pathogenesis of CT infection of 
the female upper genital tract41. Using an animal model of infection in macaques, Patton et al. evaluated whether 
spermatozoa played a role in carrying CT from the infected cervix to the upper female reproductive tract and 
in the pathogenesis of chlamydial salpingitis. Authors found that, after mating, no spermatozoa examined in 
samples taken from the upper tract or cul de sac had EBs of CT attached to their surfaces, indicating that sper-
matozoa do not play a role in the pathogenesis of CT infection. In agreement with Patton et al.41, results from 
confocal microscopy and different in vitro approaches presented herein also suggest that Chlamydia spp. do not 
attach to spermatozoa. In fact, just washing sperm suspensions previously co-incubated with Chlamydia spp. 
with supplemented BWW medium removed bacteria, since the inoculation of these washed sperm suspensions 
prevented the further infection of inoculated HeLa cells monolayers or the genital tract of artificially inseminated 
female mice. Altogether, our results suggest that Chlamydia spp. do not attach to spermatozoa in vitro. However, 
additional experimental data are needed to definitely shed light on this issue that has important implications in 
assisted reproduction technology. In fact, the incidence of CT contamination of sperm samples used in assisted 
reproduction technology and its impact on their outcomes remain uncertain.
In conclusion, we provide evidence that significantly improves the understanding of sperm cell biology 
and CT infection, supporting the notion that CT neither directly exerts deleterious effects on spermatozoa nor 
impairs male fertility. Finally, our results also indicate that CT does not attach to spermatozoa in vitro suggesting 
that these cells would not play a role in the pathogenesis of female genital infection.
Materials and Methods
CT strains. Three CT strains were used. In experiments with human sperm, three serovars of CT were used: 
CT serovar E21, CT serovar LGV L2 strain 434/Bu wild type42 or transformed with green fluorescent protein 
(GFP)-expressing plasmid p2TK2-SW2 [GFP-CT]43. In experiments with mouse sperm, C. muridarum strain 
Weiss was used22. Chlamydia spp. EBs were produced and purified as previously described44. Briefly, cultures were 
grown in RPMI-1640 medium supplemented with 20 μg/mL of gentamicin, 5% fetal bovine serum, at 37 °C and 
5% CO2. Cultures infected with Chlamydia spp. were grown for 72 h in the presence of 1 μg/mL of cycloheximide. 
Infected cell monolayers were detached by scraping and disrupted by sterile glass beads to lyse the host cells and 
release EBs. Cell debris was removed by centrifugation at 500 × g for 15 min. Chlamydia EBs were purified in a 
sucrose urografin gradient [bottom layer 50% (w/v) sucrose solution; top layer, 30% (v/v) urografin in 30 mM 
Tris–HCl buffer, pH 7.4]; at 9000 × g and 48 °C for 60 min. After one-wash step with 0.2 mm filtered PBS (pH 7.4), 
purified EBs were pelleted and resuspended in an isotonic sucrose-phosphate-glutamate (SPG) buffer and ali-
quots were stored frozen at −80 °C. Infectious titers of this suspension were determined by titration on LLCMK2 
cell monolayers. Cultures of infected cells were fixed after 48 h of incubation with methanol 100% and then air 
dried. Chlamydial inclusions were stained with FITC-monoclonal antibody against chlamydial LPS (Biomerieux, 
Marcy l′Etoile, France) and analyzed by fluorescence microscopy.
Animals. A total of 45 male and 80 female C57BL/6 mice aged 6–8 weeks were used. All animals were housed 
and maintained under specific-pathogen-free (SPF) conditions in the Animal Facility of the Facultad de Ciencias 
Químicas, Universidad Nacional de Córdoba. Animal were maintained in a 16 h light, 8 h dark cycle, at 20 ± 2 °C, 
with food and water ad libitum.
Sperm samples. Human semen samples were collected by masturbation after 2–5 days of sexual abstinence 
from a total of 54 healthy normozoospermic subjects (average age: 30, range: 20–49 years) according to World 
Health Organization (WHO) criteria45. Inclusion criteria were: sperm concentration ≥ 1.5 × 107/mL, total motil-
ity ≥ 32%, normal forms ≥ 4%, viability ≥ 58%, leukocyte concentration < 1 × 106/mL and negative sperm and 
urethral swab cultures (including CT). Fractions of highly motile sperm were isolated using a discontinuous 
Percoll gradient (45/90%). The final pellet was resuspended in Biggers-Whitten-Wittingham (BWW) medium 
supplemented with 3% bovine serum albumin (BSA fraction V; Sigma-Aldrich, St. Louis, MO, USA). Murine 
sperm was obtained from cauda epididymis from male mice. Spermatozoa were incubated in capacitating 
conditions in BWW medium containing 3% BSA (Sigma-Aldrich) for 30 min at 37 °C in a 5% CO2-saturated 
atmosphere.
Fractions of sperm samples from human and mice individuals were tested separately in a double blind manner 
for the different assays conducted in the study.
Ethical approval. This study was conducted between March 2014 and May 2016. Ethical approval for 
underwent experiments and employed methodologies using human samples was obtained from the Internal 
Review Board from the Hospital Privado de Córdoba, Córdoba, Argentina (Ref. HP 4–132). The study was 
conducted in accordance with the Declaration of Helsinki. Each semen donor participated after providing a 
signed informed consent for his inclusion in the study. All animal experiments were approved and conducted in 
accordance with guidelines of the Committee for Animal Care and Use of the Facultad de Ciencias Químicas, 
Universidad Nacional de Córdoba in strict accordance with the recommendation of the Guide for the Care and 
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Use of Laboratory Animals of the NIH (NIH publication 86–23). All efforts were made to minimize suffering and 
discomfort.
Sperm incubation with Chlamydia spp. Fractions of highly motile human and murine sperm samples 
were resuspended at a concentration of 1 × 106 sperm/mL and incubated in capacitating conditions (3% BSA sup-
plemented BWW medium) with 1 × 105, 1 × 106 and 1 × 107 EBs/mL of CT (serovar E or LGV) or C. muridarum, 
respectively, at 37 °C during 6 and 24 h (human sperm) or 30 min (murine sperm) following previously described 
protocols12–15, 46. Additional sperm fractions were incubated 6 hours in the presence of 1 × 106 colony-forming 
units (CFU)/mL of uropathogenic Escherichia coli, or 0.1 μg/mL chlamydial lipopolysaccharide (cLPS), or 5 μg/
mL LPS from E. coli (055:B5, Sigma-Aldrich), or soluble products of CT (conditioned media from HeLa cell 
cultures after 48 h of CT infection), as described13, 14, 19. As controls, fractions of human or murine sperm were 
incubated with 3% BSA supplemented BWW buffer alone. After incubation, five consecutive washes were per-
formed by adding 500 µL of 3% BSA supplemented BWW buffer to sperm suspensions and then centrifuging at 
300 × g for 5 min to remove free bacteria. Finally, different experiments and sperm quality assays were performed. 
Samples were maintained at 37 °C throughout all procedures.
Sperm motility and viability. Sperm motility and viability were analyzed according to WHO criteria45. 
Sperm motility was classified into three types: I) progressive motile sperm, II) non-progressive motile sperm and 
III) immotile sperm. No fewer than 200 gametes were examined. Results are expressed as the percentage of motile 
cells (progressive plus non-progressive spermatozoa). Sperm viability was evaluated by supravital staining with 
Eosin Y (Sigma-Aldrich). Spermatozoa that allowed the entry of the dye were classified as dead, and those that 
excluded the dye were scored as viable. The viability of 200–250 cells was assessed.
Sperm Apoptosis. Sperm apoptosis was evaluated by Annexin V/PI staining using a commercially available 
kit (Apoptosis Detection Kit II; BD Pharmingen, San Diego, CA, USA) according to the manufacturer’s instruc-
tions, and as previously described15, 46. Briefly, an aliquot of cells containing 1 × 106 sperms/ml was resuspended 
in 100 µl binding buffer, labeled with 10 µl Annexin-FITC plus 10 µl PI, incubated for 15 min in the dark, followed 
by the addition of 400 µl binding buffer and immediately transferred to a flow cytometer and analyzed. The cell 
population of interest was gated on the basis of its forward and side-scatter properties. The different labeling pat-
terns in the bivariate PI-Annexin V analysis that identified the different cell populations were FITC negative and 
PI negative and were designated as viable cells; FITC positive and PI negative as early apoptotic cells; FITC pos-
itive and PI positive as late apoptotic cells; and FITC negative and PI positive as necrotic cells. A total of 100,000 
events were acquired for each sample in a flow cytometer and analyzed. Results are expressed as percentage of 
cells.
Sperm ROS production. Sperm intracellular ROS levels were evaluated by flow cytometry using 2′,7′-dic
hlorodihydrofluorescein diacetate (DCFH-DA, 1 μM; Sigma-Aldrich), a cell-permeable probe highly sensitive to 
cellular oxidation that fluoresces when oxidized to dichlorodihydrofluorescein (DCFH). PI (Molecular Probes 
Inc., The Netherlands) was used in conjunction with DCFH-DA as a supravital stain (final concentration: 12 μM). 
Aliquots of 300 μL containing 2 × 106 spermatozoa were stained with DCFH-DA (final concentration: 1 μM) and 
incubated for 10 minutes at 37 °C with constant shaking. As positive control, 100 nM of phorbol 12-myristate 
13-acetate (PMA) (Sigma-Aldrich) was used. Samples were then analyzed by flow cytometry46. Results are 
expressed as the percentage of fluorescent living cells and the Mean Fluorescence Intensity (MFI).
Sperm Chromatin Structure Assay. The sperm chromatin structure assay was used to measure the DNA 
fragmentation index (% DFI). Briefly, at the time of the analysis, aliquots of sperm samples were mixed with 
400 μL of a low-pH (pH 1.2) detergent solution containing 0.1% Triton X-100, 0.15 mol/L NaCl, and 0.08 N HCl 
for 30 sec; this was followed by staining with 1.2 mL 6 mg/mL chromatographically purified acridine orange (AO, 
Sigma-Aldrich) in phosphate-citrate buffer (pH 6.0). Immediately after the staining, a total of 100,000 events 
were acquired for each sample in a flow cytometer and analyzed. Under these conditions, AO intercalated into 
double-stranded DNA emits green fluorescence, and AO associated with single-stranded DNA emits red fluo-
rescence. To avoid instrument drift, reference samples were used to set the red and green photomultiplier tube 
voltages. In addition, reference negative (vehicle, buffer) and positive (sperm exposed to UV light for 30 min) 
control samples of sperm were run in every assay. The ratio of single stranded (red) to single plus double stranded 
(green) fluorescence were expressed as the DFI47.
Mitochondrial membrane potential (ΔΨm). 3,3′-Dihexyloxacarbocyanine iodide [DiOC6(3)]/PI was 
used to detect ΔΨm as previously described38. Briefly, a total of 2 × 106 sperms were diluted in 300 μl of 3% BSA 
supplemented BWW medium. DiOC6(3) (Molecular Probes Inc.) was added up to a final concentration of 90 nM. 
Tubes were gently mixed and incubated for 15 min at room temperature and 5 μl of PI (6 μmol) was added to 
each tube. Flow cytometry analysis was conducted within 10 min. The test was validated using carbonyl cyanide 
m‐chlorophenylhydrazone (FCCP), an uncoupler of mitochondrial oxidative phosphorylation, which makes the 
inner mitochondrial membrane permeable to protons and induces dissipation of ΔΨm. In this control, before 
adding DiOC6(3), 4 μl of 50 mmol/l FCCP were added and the cells were incubated for 30 min at room tempera-
ture. Samples were scored as the percentage cells in the population showing high MMP47.
Plasma membrane integrity. The integrity of the spermatozoa plasma membrane was assessed using the 
LIVE/DEAD® Sperm Viability Kit (Molecular Probes, Inc.). Staining was carried out according to the manufac-
turer’s instructions. In brief, 300 μl of sperm suspension, containing 2 × 106 sperms, were incubated with SYBR-14 
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and PI to final concentrations of 1 μM and 12 μM, respectively. Samples were immediately analyzed after by flow 
cytometry. The data are expressed as percentage of viable sperms positive to SYBR-14 and negative to PI.
Lipid peroxidation. Oxidative degradation of lipids was measured using the kit BODIPY C11 (Molecular 
Probes Inc.) according to the method proposed by Aitken et al.48. In brief, 2 × 106 spermatozoa were incubated 
with BODIPY C11 (final concentration 5 μM) during 30 min at 25 °C and washed prior to being analyzed by flow 
cytometry. As positive controls, aliquots of sperm suspensions were additionally treated with t-butyl hydroperox-
ide (TBHP; 100 mM) to induce lipid peroxidation. The results are expressed as the percentage of cells exhibiting 
the green fluorescent response.
Flow cytometry. Flow cytometry analyses were conducted on a FACS CantoII flow cytometer (BD 
Biosciences), equipped with a 488 nm argon laser. Forward scatter and side scatter measurements were taken to 
generate a density plot, used to gate for sperm cells. All data were acquired and analyzed using the FlowJo 7.6 soft-
ware (Tree Star, Ashland, OR, USA) and a total of 10,000–100,000 events were collected per sample and analyzed.
Chlamydia spp. detection by PCR and qPCR. Detection of chlamydial DNA was performed by the 
polymerase chain reaction (PCR) in sperm cells fractions pre and post washes and in murine prostate and female 
genital tract tissue samples as previously described21–23. Qualitative and quantitative detection of C. muridarum 
was performed by conventional and real time PCR (qPCR), respectively, by the amplification of the Chlamydia 
spp. omp2 gene21–23. Total DNA was extracted from tissue samples after proteinase K treatment using commer-
cially available extraction columns (AccuPrep® Genomic DNA Extraction Kit, Bioneer, Daejeon, Korea) follow-
ing the specifications provided by the manufacturer. The primers used for amplification of a 100-bp fragment of 
the omp2 gene were: sense 5′-CTG CAA CAG TAT GCG CTT GTC-3′ and antisense 5′-GTC CAC ATT TTG 
TAA CCG AAC G-3′. The primers used for amplification of a 185 bp fragment of the eef2 housekeeping gene were 
as follows: sense 5′-AAG CTG ATC GAG AAG CTG GA -3′ and antisense 5′-CCC CTC GTA TAG CAG CTC 
AC -3′. Conventional PCR was performed as previously described23. A sample was considered positive when 
amplification of the omp2 gene was detected. Quantitative real time PCR was performed on a StepOneTM instru-
ment (Life technologies, Carlsbad, CA, USA) using SYBR® Select Master Mix (Life technologies). Each qPCR 
experiment was performed at least in triplicates, in a final volume of 15 µL. Each reaction contained 2 µL of DNA 
template and 1 µM of each primer (sense/antisense) of both genes (omp2 target gene and eef2 housekeeping gene). 
A single initial denaturation step of 15 min at 95 °C was followed by 40 cycles of 15 sec at 95 °C (denaturation), 
30 sec at 60 °C (annealing) and 30 sec at 72 °C (elongation). Negative and positive controls were included in each 
run. After performing thermal cycling, qPCR amplification data were analyzed using StepOne software (Applied 
Biosystems, Foster City, CA, USA).
Assessment of CT attachment to human spermatozoa by confocal microscopy. Fractions of 
highly motile human sperm samples containing 1 × 106 spermatozoa/mL were in vitro incubated with 3% BSA 
supplemented BWW medium alone or with 1 × 105, 1 × 106 and 1 × 107 EBs/mL of green fluorescent GFP-CT 
during 6 h at 37 °C, as described above. After five consecutive washes and centrifuging at 300 xg for 5 min to 
remove free bacterial EBs, sperm smears were prepared on glass slides, air-dried, fixed with 4% paraformaldehyde 
in PBS pH 7.4 at room temperature for 10 min, stained with DAPI (Wako Pure Chemical Industries, Richmond, 
VA, USA) and counterstained with 0.01% Evans blue for 10 minutes. Slides mounted with FluorSave (Calbiochem, 
San Diego, CA, USA) were visualized with an Olympus FV1200 laser scanning confocal microscope (Olympus, 
Center Valley, PA, USA). Images were captured using an objective PLAPON 60X (1.42 NA). Fluorophore signals 
were acquired in sequential mode and images were analyzed using Olympus software (Olympus).
Infection assessment of in vitro cultured HeLa cells after inoculation with sperm pre-incubated 
with Chlamydia spp. Seventy to 80% confluent HeLa cell monolayers cultured at 37 °C/5% CO2 were inoc-
ulated with 1 × 106 human or murine spermatozoa pre-incubated in vitro with 1 × 105, 1 × 106 or 1 × 107 EBs 
of CT or C. muridarum/million sperm, respectively, before and after 5 consecutive washes as described above. 
After 48 h of culture, infection of cultures was assessed by the detection of chlamydial inclusion bodies, as pre-
viously described44. Cultures were fixed after 48 h of incubation with methanol 100% and then air dried. To 
detect chlamydial inclusion bodies, cell monolayers were then stained with FITC-monoclonal antibody against 
chlamydial LPS (Biomerieux) and analyzed by fluorescence microscopy.
Determination of chlamydial infection in the genital tract of female mice inseminated with 
murine sperm in vitro pre-incubated with C. muridarum. To test whether C. muridarum attaches 
to murine spermatozoa, experiments using a mouse model of infection49 were also performed. Six-8 week old 
female C57BL/6 mice received three subcutaneous doses of 2.5 mg/mouse of medroxyprogesterone acetate 
(Sigma-Aldrich) on days 13, 10 and 3 before vaginal insemination. To confirm that all mice were on diestrous, 
vaginal cytology was checked before insemination. Murine sperm were in vitro incubated with EBs of C. 
muridarum in capacitating conditions, washed 5 times and then intravaginally inoculated in oestrous female 
C57BL/6 mice, as described above. Four experimental groups were included: the sham infected group insem-
inated with 30 µL of a solution containing 1 × 106 sperm pre-incubated with vehicle alone (BWW buffer, neg-
ative control group); the positive control group inseminated with 30 µL of a solution containing 1 × 106 sperm 
pre-incubated with 1 × 107 EBs of C. muridarum without subsequent washings; one group inseminated with 30 µL 
of a solution containing 1 × 106 sperm pre-incubated with 1 × 106 EBs of C. muridarum and then washed 5 times; 
and one group inseminated with 30 µL of a solution containing 1 × 106 sperm pre-incubated with 1 × 107 EBs of 
C. muridarum and then washed 5 times. To assay infection, vaginal lavages were collected on day 7 after insemi-
nation; then, animals were euthanized on day 15 after insemination and vagina, uterus and ovaries were excised. 
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Total DNA extraction from vaginal swabs and tissue samples was performed and the presence of C. muridarum 
was assayed by PCR and qPCR as described above.
Animal model of C. muridarum infection of the MGT. As previously described23, 6–8 week old male 
C57BL/6 mice were inoculated in the meatus urethra with 1 × 108 EBs of C. muridarum in 20 μL of SPG. For the 
inoculation, animals (n = 6) were anesthetized and put on their backs, the prepuce was pulled back and the inocu-
lum was placed on the meatus urethra, simulating its natural infection path to the genital tract. A control group of 
animals (n = 6) was sham infected with 20 μL of SPG. This time point was considered day 0 of infection. After 15 
days of infection, males were mated with sexually mature female C57BL/6 mice in order to assess different male 
fertility parameters. Then, males from the infected and control groups were euthanized (20 days post inoculation) 
to confirm C. muridarum infection of the MGT. Once animals were euthanized, the prostate was excised. Total 
DNA extraction from prostate tissue samples was performed and the presence of C. muridarum was assayed by 
PCR and qPCR as described above.
Mating Studies. Sham infected and infected male C57BL/6 mice were mated with normally cycling female 
C57BL/6 mice, as previously described22. Six males per experimental group were mated to 3 females each. A total 
of 36 females were tested, including 18 females per infected group and 18 per sham infected/control group. On 
the morning of proestrus-estrous each female was transferred to the appropriate male cage at approximately 5:00 
p.m. for overnight breeding. Females were removed from the male cages early the next morning. Sperm or a cop-
ulatory plug in the vaginal lavage was considered evidence of mating. This day was designated day 0 of gestation.
Fertility Parameters. Females were sacrificed on day 18 of gestation. The uterus was exposed and the 
number of implantation sites was recorded. Ovaries were exposed to count the number of corpora lutea. Live, 
dead and resorbed fetuses were noted. Potency was calculated as the ratio of females inseminated to the number 
exposed for mating × 100. The fertility index was calculated as the ratio of the number of implantation sites to the 
number of corpora lutea. Fecundity was calculated as the ratio of the number of males that sired at least 1 viable 
fetus to the total number exposed for mating × 100. Pre-implantation embryo loss was determined by the equa-
tion, (number of corpora lutea - number of implantation sites/number of corpora lutea) × 100. Post-implantation 
embryo loss was determined by the equation, (number of implantation sites - number of live fetuses/number of 
implantation sites) × 100.
Statistical analyses. Statistical analysis was performed using one-way or two-way ANOVA with Bonferroni 
post hoc test analysis. Mean ± SD are represented in the graphs. Statistical tests were performed using the 
GraphPad Prism 5.0 software. The p value < 0.05 was considered significant in all analyses. Compromise power 
analyses using G*Power3 data analysis program50 was performed to determine the statistical power (>0.86) to 
exclude the possibility of type II error.
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